Sharda Cropchem Investor Presentation: Key Takeaways
Sharda Cropchem reported Q1 FY27 revenue growth of 9% YoY to Rs 1,074 crores. EBITDA grew 25% to Rs 178 crores with margins expanding to 16.6% despite FX headwinds.
- Call
- Guides 12% growth
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
Sharda Cropchem reported Q1 FY27 revenue growth of 9% YoY to Rs 1,074 crores. EBITDA grew 25% to Rs 178 crores with margins expanding to 16.6% despite FX headwinds.
Sharda Cropchem reported Q1 FY27 revenue of ₹1,074 Cr (+9% YoY) and EBITDA of ₹178 Cr (+25% YoY). The company continues to leverage its asset-light, IP-led registration model.
Sharda Cropchem Ltd reported revenue from operations of ₹1,074 Cr (+9.0% YoY) and net profit of ₹88 Cr (-38.4% YoY) for Q1 FY27.
Sharda Cropchem reports its best-ever financial year in FY26, driven by gross margin expansion and strong volume growth in Europe.
Sharda Cropchem delivered strong FY26 results with a 22% revenue increase and 124% PAT growth. The company maintains an asset-light model focused on product registrations and global distribution across 80+ countries.
Sharda Cropchem Ltd reported revenue from operations of ₹2,065 Cr (+12.9% YoY) and net profit of ₹318.7 Cr (+56.5% YoY) for Q4 FY26.